Organization
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
7 clinical trials
2 abstracts
Clinical trial
A Single-arm, Open-label Clinical Study to Assess the Safety and Efficacy of the C752 CAR-T Cells for Patients With CD19+ Refractory/Relapsed B Cell Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2024-12-24
Clinical trial
Clinical Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T Injection in the Treatment of Relapsed and Refractory Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2026-08-01
Clinical trial
An Open Label, Single-site, Dose-escalation Study Aiming to Evaluate the Efficacy and Safety of Anti-CD19 CAR-T Manufactured by OlyCAR Platform(OlyCAR-019) in the Treatment of Relapsed/ Refractory(r/r) B-Cell MalignanciesStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2024-12-05
Clinical trial
A Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Anti-CD19 Universal CAR-T Cells in the Treatment of CD19+ Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia and Relapsed/Refractory B-cell Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
A Phase1/phase2，Single-arm, Open-label Study of RD14-01 in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-08-08
Clinical trial
An Investigator-initiated Trial Evaluating the Efficacy and Safety of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of Relapsed / Refractory(r/r) Multiple Myeloma(MM)Status: Recruiting, Estimated PCD: 2025-02-01
Abstract
Examining safety and durable disease remission in R/R B-ALL after autologous CD19-directed CAR T cells produced by novel PRIMCAR manufacture platform.Org: Chongqing Precision Biotech Co., Ltd., 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China,
Abstract
Safety and efficacy profile of a very low dose of MC-1-50 for treatment of r/r NHL.Org: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, China, Chongqing Precision Biotech Co., Ltd., Chongqing, China,